Cogentix Medical (CGNT) Misses Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CGNT Hot Sheet
Join SI Premium – FREE
Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of $0.16, $0.06 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $125 million versus the consensus estimate of $129.55 million.
For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- Cognyte Investigative Analytics and Operational Intelligence Solutions for Law Enforcement Highlight IACP 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
